Louise Hjerrild Zeuthen,Jan Amstrup,Thomas Aaskov Pedersen
申请号：
US16335060
公开号：
US20190361007A1
申请日:
2017.10.24
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to a bioassay of insulin peptide in oral formulations and low affinity insulin peptides in liquid formulations, by for quantifying phosphorylated Akt, thereby avoiding the interference of excipients in potency determination.
